首页|吡拉西坦在重型颅脑损伤患者中的应用效果及对脑水肿、神经功能的影响

吡拉西坦在重型颅脑损伤患者中的应用效果及对脑水肿、神经功能的影响

扫码查看
目的 探讨吡拉西坦在重型颅脑损伤患者中的应用效果及对脑水肿、神经功能的影响。方法 回顾性选取2021年1月至2022年12月于上海交通大学医学院苏州九龙医院进行常规治疗联合吡拉西坦治疗的40例重型颅脑损伤患者为观察组,倾向性评分匹配40例进行常规治疗的患者为对照组。比较两组的总有效率、不良反应总发生率、治疗前后的脑水肿指标(周围脑水肿体积及血肿侧扰动系数)、神经功能评分[美国国立卫生研究院卒中量表(NIHSS)评分]及神经损伤相关血液指标[血清神经元特异性烯醇化酶(NSE)、S100B蛋白(S100B)及胶质纤维酸性蛋白(GFAP)]。结果 观察组治疗总有效率高于对照组(P<0。05);两组不良反应总发生率比较,差异无统计学意义(P>0。05);治疗前两组脑水肿指标、神经功能受损程度及神经损伤相关血液指标比较,差异无统计学意义(P>0。05),治疗1、2周后观察组的脑水肿指标、神经功能受损程度及神经损伤相关血液指标均低于对照组(P<0。05)。结论 吡拉西坦在重型颅脑损伤患者中的临床疗效较好,有助于改善本类患者的脑水肿及神经损伤。
The application effect of piracetam in patients with severe craniocerebral injury and its impact on brain edema and neurological function
Objective To explore the application effect of piracetam in patients with severe craniocerebral injury and its impact on brain edema and neurological function.Methods A retrospective study was conducted on 40 patients with severe craniocerebral injury who underwent routine treatment combined with piracetam therapy at Suzhou Kowloon Hospital,Shanghai Jiao Tong University School of Medicine from January 2021 to December 2022,who were considered as the observation group,and 40 patients with propensity score matching who underwent routine treatment were considered as the control group.The total effective rate,incidence of adverse reactions,brain edema indicators(peripheral brain edema volume and disturbance coefficient in hematoma side),neurological function scores(National Institutes of Health stroke scale[NIHSS]score),and neurological injury-related blood indicators(serum neuron-specific enolase[NSE],S100B protein(S100B),and glial fibrillary acidic protein[GFAP])were compared between the two groups before and after treatment.Results The total effective rate in the observation group was significantly higher than that in the control group(P<0.05).The total incidence rate of adverse reactions between the two groups was not statistically significant(P>0.05).Before treatment,there were no statistically significant differences in brain edema indicators,degree of neurological impairment,and neurological injury-related blood indicators between the two groups(P>0.05).After 1 and 2 weeks of treatment,brain edema indicators,degree of neurological impairment,and neurological injury-related blood indicators in the observation group were significantly lower than the results and scores in the control group(P<0.05).Conclusion Piracetam has good clinical efficacy in treating patients with severe craniocerebral injury,which helps to improve brain edema and neurological injury in such patients.

PiracetamSevere craniocerebral injuryApplication effectBrain edemaNeurological function

杨兰

展开 >

上海交通大学医学院苏州九龙医院药学部,江苏苏州 215028

吡拉西坦 重型颅脑损伤 应用效果 脑水肿 神经功能

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(8)
  • 22